Skip to search boxSkip to navigationSkip to main content

Are Herbal-peptides Effective as Adjunctive Therapy in Coronavirus Disease COVID-19?

  • Elahe Aleebrahim-Dehkordi
    ,
  • Faezeh Soveyzi
    ,
  • ,
  • Mahmoud Rafieian-Kopaei(corresponding author)
*Corresponding author for this work
Research output:
Contribution to journal
Article
Research
Peer-review

About the research

Background: Plant antiviral peptides (AVP) are macromolecules that can inhibit the pathogenesis of viruses by affecting their pathogenic mechanism, but most of these peptides can bind to cell membranes, inhibit viral receptors, and prevent viruses. Recently, due to the coronavirus pandemic, the availability of appropriate drugs with low side effects is needed. In this article, the importance of plant peptides in viral inhibition, especially viral inhibition of the coronavirus family, will be discussed. Methods: By searching the databases of PubMed, Scopus, Web of Science, the latest articles on plant peptides effective on the COVID-19 virus were collected and reviewed. Results: Some proteins can act against the COVID-19 virus by blocking sensitive receptors in COVID-19, such as angiotensin-converting enzyme 2 (ACE2). The 23bp sequence of the ACE2 alpha receptor chain can be considered as a target for therapeutic peptides. Protease and RNAP inhibitors and other important receptors that are active against COVID-19 should also be considered. Conclusion: Herbal medicines with AVP, especially those with a long history of antiviral effects, might be a good choice in complement therapy against the COVID-19 virus.

Research output information

Output type

Research output:
Contribution to journal
Article
Research
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 29-34 (6 pages)

Journal (Volume, Issue Number)

Current Drug Research Reviews (Volume 15, Issue 1)

Publication milestones

  • Published - 03/2023

Publication status

Published - 03/2023

ISSN

2589-9775